Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma

Blood Cancer Journal, Published online: 25 July 2023; doi:10.1038/s41408-023-00882-yBortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma

Source: Blood Cancer Journal - July 25, 2023 Category: Hematology Authors: Carlyn Rose Tan Andriy Derkach David Nemirovsky Amanda Ciardiello Benjamin Diamond Malin Hultcrantz Hani Hassoun Sham Mailankody Urvi Shah Kylee Maclachlan Dhwani Patel Oscar B. Lahoud Heather J. Landau David J. Chung Gunjan L. Shah Michael Scordo Sergio Source Type: research